In a groundbreaking move, President Trump has issued an executive order aimed at ending the price discrimination faced by American consumers in the pharmaceutical market. This order seeks to ensure that Americans pay the same low prices for medications as those in other developed nations, addressing the long-standing issue of subsidizing global pharmaceutical profits.
President Trump's upcoming tariffs on Canadian steel imports may benefit U.S. manufacturers like Capone Iron Corporation, while sparking fears of higher consumer prices and retaliation from other countries.
